Aurobindo drugs get US FDA nod

Aurobindo Pharma Ltd has announced that the US Food and Drug Administration (US FDA) has given the final approval for the company's tentatively approved products "� Zidovudine tablets 300 mg and Zidovudine oral solution 50 mg/5 ml "� with the latter being the first oral solution approval for the company.

Aurobindo has also informed in a press release that it is the first generic company to have final approval for Zidovudine oral solution 50 mg/5 ml. With these two final approvals, Aurobindo has added some more products to sell in the regulated market.

AZT, an anti-retroviral drug that is also known as Zidovudine, helps prevent the AIDS virus from reproducing in the body. It is often used in combination with other medications to treat HIV infection.